Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease.

American journal of medical genetics - 15 Oct 1993

Kurth M C, Kurth J H

Abstract excerpt

Aberrant detoxification of environmental agents may be the basis for an inherited predisposition to Parkinson's disease. A CYP2D6 genetic marker of the debrisoquine hydroxylase "poor metabolizer" phenotype was found to be significantly increased in Parkinson's disease patients compared to controls, as has been shown in previous studies. Presence of this marker gives an odds ratio of 1.86 for Parkinson's disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Alleles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Genetic Markers

Share to Genetic Variation

Share to Heterozygote

Share to Phenotype

Source

Identifiers

PMID: 8291573
DOI: 10.1002/ajmg.1320480311

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease.PMID 8291573Read ↗

Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.Semantic proximity Read ↗

CYP2D6 allelic frequencies in young-onset Parkinson's disease.Semantic proximity Read ↗

Mutant debrisoquine hydroxylation genes in Parkinson's disease.Semantic proximity Read ↗

Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families.Semantic proximity Read ↗

Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.Semantic proximity Read ↗

The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease.Semantic proximity Read ↗

CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.Semantic proximity Read ↗

Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.Semantic proximity Read ↗

Further evidence for the association of CYP2D6*4 gene polymorphism with Parkinson’s disease: a case control studySemantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

Genotyping of CYP2D6 in Parkinson's disease.Semantic proximity Read ↗

CYP2D6 polymorphism in Parkinson's disease: the Rotterdam Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.